✦ LIBER ✦

Taste and olfactory disturbances after treatment for acne with isotretinoin, a 13-cis-isomer of retinoic acid

✍ Scribed by E. Heise; A. Schnuch

Book ID: 112278226
Publisher: Springer-Verlag
Year: 1990
Tongue: English
Weight: 172 KB
Volume: 247
Category: Article
ISSN: 0302-9530
DOI: 10.1007/bf00179013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effect of oral isotretinoin (13-cis

The effect of oral isotretinoin (13-cis retinoic acid) on hearing systems in patients with acne vulgaris: a prospective study

✍ Hayriye Karabulut; Ayse Serap Karadag; Baran Acar; Muharrem Dagli; Ismail Karabu 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB

Serum levels of albumin, triglycerides,

Serum levels of albumin, triglycerides, total protein and glucose in rats are altered after oral treatment with low doses of 13-cis-retinoic acid or all-trans-retinoic acid

✍ F. J. Cisneros; B. J. Gough; R. E. Patton; S. A. Ferguson 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 277 KB 👁 1 views

Currently used to treat severe acne, 13-cis-retinoic acid (13-cis-RA) is under investigation for its anticancer effects as is the isomer, all-trans-retinoic acid (all-trans-RA). Here, the effects of oral 13-cis-RA or all-trans-RA treatment on serum chemistry, leptin and adiponectin levels were evalu

Interferon-α-2a with or without 13-cis r

Interferon-α-2a with or without 13-cis retinoic acid in patients with progressive, measurable metastatic renal cell carcinoma : Results of a randomized Phase II study (European Organization for Research and Treatment of Cancer Study 30951)

✍ Sophie D. Fosså; Gerald H. J. Mickisch; Pieter H. M. De Mulder; Simon Horenblas; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

## Background: In patients with metastatic renal cell carcinoma (mrcc), interferon-alpha (ifn) monotherapy leads to response rates of 5-15%, dependent on the selection of patients. in 1995, preclinical and clinical data indicated an improvement of these results if ifn was combined with 13-cis retin

Randomized phase II/III trial of interfe

Randomized phase II/III trial of interferon alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell carcinoma: The European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951): Aass N, De Mulder PHM, Mickisch GHJ, Mulders P, van Oosterom AT, van Poppel H, Fossa SD, de Prijck L, Sylvester RJ, Department of Clinical Cancer Research, The Norwegian Radium Hospital, Oslo, Norway

✍ Robert Flanigan 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 42 KB